Literature DB >> 20024502

Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin.

L Yang1, C Manithody, S H Qureshi, A R Rezaie.   

Abstract

Heparin promotes the antithrombin (AT) inactivation of factors IXa (fIXa) and Xa (fXa) through a conformational activation of the serpin and also by a template mechanism in the presence of physiological levels of Ca2+. Recently, it was reported that heparin induces conformational changes in the active-sites of fIXa and fXa, raising the possibility that heparin also modulates the reactivity of these proteases with AT by this mechanism. To test this possibility, we prepared an AT mutant in which four critical heparin-binding residues of the serpin (Arg-45, Arg-46, Lys-114, and Arg-129) were replaced with non-basic residues. This mutant lost its affinity for heparin, but retained its normal reactivity with coagulation proteases. Thus, the high-affinity AT-binding pentasaccharide fragment of heparin had no cofactor effect on the reactivity of the AT mutant with coagulation proteases. Full-length heparin-concentration dependence of the AT inhibition of fIXa and fXa revealed that in contrast to a greater than 4-5 orders of magnitude accelerating effect for heparin on the AT inhibition of fIXa and fXa, heparin exhibits a negligible cofactor effect (<2-fold) on the mutant AT inhibition of these proteases. The same results were obtained for the mutant AT inhibition of thrombin and factor VIIa, however, heparin accelerated the mutant AT inhibition of factor XIa ~10-fold. We conclude that, with the exception of factor XIa, heparin-mediated conformational modulation of the active-sites of coagulation proteases makes a minor contribution to the regulation of these proteases by AT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024502      PMCID: PMC2818343          DOI: 10.1160/TH09-08-0585

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  28 in total

1.  Structural mobility of antithrombin and its modulation by heparin.

Authors:  R Carrell; R Skinner; L Jin; J P Abrahams
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

2.  The anticoagulant activation of antithrombin by heparin.

Authors:  L Jin; J P Abrahams; R Skinner; M Petitou; R N Pike; R W Carrell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 3.  Initial treatment of venous thromboembolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Joseph Emmerich; Alessandra Bura; Jeffrey I Weitz
Journal:  Thromb Haemost       Date:  2006-09       Impact factor: 5.249

Review 4.  Emerging anticoagulants for the treatment of venous thromboembolism.

Authors:  Jeffrey I Weitz
Journal:  Thromb Haemost       Date:  2006-09       Impact factor: 5.249

5.  Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.

Authors:  Daniel J D Johnson; Wei Li; Ty E Adams; James A Huntington
Journal:  EMBO J       Date:  2006-04-13       Impact factor: 11.598

6.  The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.

Authors:  Tina M Misenheimer; Yang Buyue; John P Sheehan
Journal:  Biochemistry       Date:  2007-06-12       Impact factor: 3.162

7.  Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa.

Authors:  A R Rezaie
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

8.  Characterization of a heparin binding site on the heavy chain of factor XI.

Authors:  M Zhao; T Abdel-Razek; M F Sun; D Gailani
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

9.  Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.

Authors:  Steven T Olson; Richard Swanson; Elke Raub-Segall; Tina Bedsted; Morvardi Sadri; Maurice Petitou; Jean-Pascal Hérault; Jean-Marc Herbert; Ingemar Björk
Journal:  Thromb Haemost       Date:  2004-11       Impact factor: 5.249

10.  Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions.

Authors:  Lei Jin; Pramod Pandey; Robert E Babine; Joan C Gorga; Katherine J Seidl; Ellen Gelfand; David T Weaver; Sherin S Abdel-Meguid; James E Strickler
Journal:  J Biol Chem       Date:  2004-11-15       Impact factor: 5.157

View more
  9 in total

1.  Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain.

Authors:  Kristine S Alexander; Michael G Fried; David H Farrell
Journal:  Biochemistry       Date:  2012-04-15       Impact factor: 3.162

2.  Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury.

Authors:  Yina Ma; Jinli Wang; Junjie Gao; Hui Yang; Yanqing Wang; Chandrashekhara Manithody; Ji Li; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-09-18       Impact factor: 5.249

3.  Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteases.

Authors:  Brian L Henry; Jay N Thakkar; Aiye Liang; Umesh R Desai
Journal:  Biochem Biophys Res Commun       Date:  2011-12-01       Impact factor: 3.575

4.  Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.

Authors:  Likui Yang; Qiulan Ding; Xin Huang; Steven T Olson; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-05-02       Impact factor: 3.162

5.  Extracellular Histones Bind Vascular Glycosaminoglycans and Inhibit the Anti-Inflammatory Function of Antithrombin.

Authors:  Indranil Biswas; Sumith R Panicker; Xiaofeng S Cai; Hemant Giri; Alireza R Rezaie
Journal:  Cell Physiol Biochem       Date:  2021-10-16

6.  Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin.

Authors:  L Yang; P Dinarvand; S H Qureshi; A R Rezaie
Journal:  Thromb Haemost       Date:  2014-02-13       Impact factor: 5.249

7.  Antithrombin is protective against myocardial ischemia and reperfusion injury.

Authors:  J Wang; Y Wang; J Wang; J Gao; C Tong; C Manithody; J Li; A R Rezaie
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

8.  Antithrombin protects against Plasmodium falciparum histidine-rich protein II-mediated inflammation and coagulation.

Authors:  Indranil Biswas; Sumith R Panicker; Hemant Giri; Xiaofeng S Cai; Alireza R Rezaie
Journal:  Blood Adv       Date:  2022-02-08

9.  Effects of chitin and sepia ink hybrid hemostatic sponge on the blood parameters of mice.

Authors:  Wei Zhang; Yu-Lin Sun; Dao-Hai Chen
Journal:  Mar Drugs       Date:  2014-04-10       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.